Skip to content

Clinical trials

Phase 2/3 Carcinoma, Non-Small-Cell Lung trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2/3 Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20141
20151
20171
20181
20203
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting3
Completed2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Chang Gung Memorial Hospital2
Hoffmann-La Roche2
Alpha Biopharma (Jiangsu) Co., Ltd.1
Bristol-Myers Squibb1
Clovis Oncology, Inc.1
GlaxoSmithKline1
Mirati Therapeutics Inc.1
PhytoHealth Corporation1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms3
Neoplasms3
Brain Neoplasms2
Fatigue1
Neoplasm Metastasis1
Recurrence1
Respiratory Tract Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.